Module 9 12 Part 6 Flashcards
Q: What is necessary to ensure the success of antimicrobial therapy in treating an infection?
Adequate drug concentration at the infection site is essential for success.
Q: How should dosages be adjusted for antibiotics used in infection treatment?
Dosages should be adjusted to achieve drug concentrations equal to or greater than the MIC (Minimal Inhibitory Concentration) for the specific infection.
Q: What is the ideal range of drug levels concerning the MIC for effective infection treatment?
Having drug levels 4 to 8 times the MIC is often desirable for successful treatment.
Q: What factors influence the duration of antimicrobial therapy for an infection?
The duration depends on variables like the patient’s host defenses, the site of the infection, and the identity of the infecting organism.
Q: Why is it crucial for patients to complete their full course of antibiotics?
Completing the full course of antibiotics is essential to prevent recurrent infections and the development of more drug-resistant organisms.
Q: What should patients do even if their symptoms improve before the antibiotic course ends?
Patients should continue taking the antibiotics for the entire prescribed duration.
Q: What can happen if patients discontinue antibiotics prematurely?
Early discontinuation is a common cause of recurrent infection, and the organisms responsible for relapse are likely to be more drug-resistant.
Q: Why is it important to educate patients about finishing their prescribed antibiotic course?
Educating patients about finishing their prescribed antibiotic course is important to ensure proper treatment and avoid the development of drug resistance.
Q: When is combination antibiotic therapy considered appropriate?
Combination antibiotic therapy is considered appropriate in specific situations, particularly when it has the potential to be lifesaving.
Q: Should the routine use of two or more antibiotics be encouraged?
No, the routine use of multiple antibiotics should be discouraged.
Q: What is the usual approach when an infection is caused by a single, identified microbe?
When a single microbe is responsible for an infection, the usual approach is to treat it with a single appropriate antibiotic.
Q: What is an additive response in combination antibiotic therapy?
An additive response occurs when the combined antimicrobial effect of two antibiotics equals the sum of their individual effects.
Q: What is a potentiative (synergistic) interaction in antibiotic combination therapy?
A potentiative interaction happens when the effect of the antibiotic combination is greater than the sum of the effects of the individual drugs.
Q: Can you provide an example of a classic potentiative interaction with antibiotics?
Trimethoprim plus sulfamethoxazole is a classic example of a potentiative interaction as they inhibit sequential steps in the synthesis of tetrahydrofolic acid.
Q: What is antagonism in combination antibiotic therapy?
Antagonism occurs when a combination of two antibiotics is less effective than one of the agents used alone.
Q: When is antagonism most likely to occur in antibiotic combination therapy?
Antagonism is most likely when a bacteriostatic antibiotic, like tetracycline, is combined with a bactericidal drug, such as penicillin.
Q: Why does antagonism happen when combining a bacteriostatic and a bactericidal antibiotic?
Bactericidal drugs are effective against actively growing bacteria, and the presence of a bacteriostatic drug can suppress bacterial growth, reducing the effectiveness of the bactericidal drug.
Q: What are the consequences of antagonism between antibiotics when host defenses are compromised?
When host defenses are compromised, antagonism between antibiotics can have dire consequences.
Q: When is it common to use multiple antibiotics in severe infections?
Multiple antibiotics are commonly used for the initial treatment of severe infections of unknown cause, particularly in individuals with neutropenia.
Q: Why is broad-spectrum antibiotic coverage used in these situations?
Broad-spectrum antibiotics are used because the specific infecting organism is unknown, and this approach covers a wide range of potential pathogens.
Q: How is the scope of broad coverage determined in antibiotic therapy for severe infections?
The extent of broad coverage depends on the clinician’s ability to narrow down potential pathogens based on clinical evaluation.
Q: When can drug selection be adjusted in this context?
Drug selection can be adjusted once the identity of the infecting microbe is known.
Q: What is the importance of obtaining samples for culture before starting drug therapy in severe infections?
It is crucial to obtain samples for culture before initiating drug therapy to accurately identify the infecting organism and guide antibiotic treatment.
Q: Can infections be caused by multiple types of microorganisms?
Yes, infections can be caused by more than one microbial species.